Dysregulated Immune Profiles for Skin and Dendritic Cells Are Associated with Increased Host Susceptibility to Haemophilus ducreyi Infection in Human Volunteers (cid:1) †

In experimentally infected human volunteers, the cutaneous immune response to Haemophilus ducreyi is orchestrated by serum, polymorphonuclear leukocytes, macrophages, T cells, and myeloid dendritic cells (DC). This response either leads to spontaneous resolution of infection or progresses to pustule formation, which is associated with the failure of phagocytes to ingest the organism and the presence of Th1 and regulatory T cells. In volunteers who are challenged twice, some subjects form at least one pustule twice (PP group), while others have all inoculated sites resolve twice (RR group). Here, we infected PP and RR subjects with H. ducreyi and used microarrays to profile gene expression in infected and wounded skin. The PP and RR groups shared a core response to H. ducreyi . Additional transcripts that signified effective immune function were differentially expressed in RR infected sites, while those that signified a hyperinflammatory, dysregulated response were differentially expressed in PP infected sites. To examine whether DC drove these responses, we profiled gene expression in H. ducreyi- infected and uninfected monocyte-derived DC. Both groups had a common response that was typical of a type 1 DC (DC1) response. RR DC exclusively expressed many additional transcripts indicative of DC1. PP DC exclusively expressed differentially regulated transcripts characteristic of DC1 and regulatory DC. The data suggest that DC from the PP and RR groups respond differentially to H. ducreyi. PP DC may promote a dysregulated T-cell response that contributes to phagocytic failure, while RR DC may promote a Th1 response that facilitates bacterial clearance. related 2-fold

[1]  B. Katz,et al.  Haemophilus ducreyi Partially Activates Human Myeloid Dendritic Cells , 2007, Infection and Immunity.

[2]  J. O’Shea,et al.  TH-17 differentiation: of mice and men , 2007, Nature Immunology.

[3]  Kathleen M. Smith,et al.  Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.

[4]  F. Sallusto,et al.  Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells , 2007, Nature Immunology.

[5]  D. Ho,et al.  Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication. , 2007, The Journal of infectious diseases.

[6]  Lawrence Steinman,et al.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[7]  B. Gibson,et al.  Identification of Genes Involved in the Expression of Atypical Lipooligosaccharide Structures from a Second Class of Haemophilus ducreyi , 2006, Infection and Immunity.

[8]  M. E. Bauer,et al.  Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. , 2006, Microbes and infection.

[9]  I. Julkunen,et al.  IL‐21 enhances SOCS gene expression and inhibits LPS‐induced cytokine production in human monocyte‐derived dendritic cells , 2006, Journal of leukocyte biology.

[10]  K. Fortney,et al.  Expression of Haemophilus ducreyi Collagen Binding Outer Membrane Protein NcaA Is Required for Virulence in Swine and Human Challenge Models of Chancroid , 2006, Infection and Immunity.

[11]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[12]  J. Kolls Oxidative stress in sepsis: a redox redux. , 2006, The Journal of clinical investigation.

[13]  C. Elkins,et al.  A DltA Mutant of Haemophilus ducreyi Is Partially Attenuated in Its Ability To Cause Pustules in Human Volunteers , 2006, Infection and Immunity.

[14]  Howard J. Edenberg,et al.  Effects of filtering by Present call on analysis of microarray experiments , 2006, BMC Bioinformatics.

[15]  E. Hansen,et al.  Haemophilus ducreyi Targets Src Family Protein Tyrosine Kinases To Inhibit Phagocytic Signaling , 2005, Infection and Immunity.

[16]  T. K. van den Berg,et al.  The macrophage scavenger receptor CD163. , 2005, Immunobiology.

[17]  James J. Campbell,et al.  Trafficking Pathways and Characterization of CD4 and CD8 Cells Recruited to the Skin of Humans Experimentally Infected with Haemophilus ducreyi , 2005, Infection and Immunity.

[18]  W. Cade,et al.  Killing of dsrA Mutants of Haemophilus ducreyi by Normal Human Serum Occurs via the Classical Complement Pathway and Is Initiated by Immunoglobulin M Binding , 2005, Infection and Immunity.

[19]  G. Trinchieri,et al.  CD85j (Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2) Inhibits Human Osteoclast-Associated Receptor-Mediated Activation of Human Dendritic Cells1 , 2005, The Journal of Immunology.

[20]  C. Elkins,et al.  Haemophilus ducreyi Outer Membrane Determinants, Including DsrA, Define Two Clonal Populations , 2005, Infection and Immunity.

[21]  R. Kaslow,et al.  Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. , 2005, The Journal of infectious diseases.

[22]  L. Zhao,et al.  Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Kaslow,et al.  Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. , 2004, The Journal of infectious diseases.

[24]  K. Mills,et al.  Regulatory T cells: friend or foe in immunity to infection? , 2004, Nature Reviews Immunology.

[25]  S. Opdal,et al.  IL-10 gene polymorphisms in infectious disease and SIDS. , 2004, FEMS immunology and medical microbiology.

[26]  E. Hansen,et al.  Expression of the LspA1 and LspA2 Proteins by Haemophilus ducreyi Is Required for Virulence in Human Volunteers , 2004, Infection and Immunity.

[27]  C. Elkins,et al.  A Novel Lectin, DltA, Is Required for Expression of a Full Serum Resistance Phenotype in Haemophilus ducreyi , 2004, Infection and Immunity.

[28]  M. Russo,et al.  What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells? , 2004, Microbes and infection.

[29]  P. van Endert,et al.  A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. , 2003, Journal of immunological methods.

[30]  M. E. Bauer,et al.  Differences in Host Susceptibility to Disease Progression in the Human Challenge Model of Haemophilus ducreyi Infection , 2003, Infection and Immunity.

[31]  E. Hansen,et al.  Inhibition of Phagocytosis by Haemophilus ducreyi Requires Expression of the LspA1 and LspA2 Proteins , 2003, Infection and Immunity.

[32]  Masahiro Yamamura,et al.  Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease , 2003, Science.

[33]  J. Hazelzet,et al.  Host genetic determinants of Neisseria meningitidis infections. , 2003, The Lancet. Infectious diseases.

[34]  M. Jenkins,et al.  Antigen presentation to naive CD4 T cells in the lymph node , 2003, Nature Immunology.

[35]  William C. Ray,et al.  Proteome of Haemophilus ducreyi by 2-D SDS-PAGE and mass spectrometry: strain variation, virulence, and carbohydrate expression. , 2003, Journal of proteome research.

[36]  Damien Chaussabel,et al.  Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. , 2003, Blood.

[37]  B. Beutler,et al.  Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Akira,et al.  Activation and regulation of Toll-like receptors 2 and 1 in human leprosy , 2003, Nature Medicine.

[39]  A. Aderem,et al.  Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling1 , 2003, The Journal of Immunology.

[40]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[41]  J. McClintick,et al.  Reproducibility of oligonucleotide arrays using small samples , 2003, BMC Genomics.

[42]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[43]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[44]  J. Orenstein,et al.  Mycobacterium avium Infection and Modulation of Human Macrophage Gene Expression , 2002, The Journal of Immunology.

[45]  R. Hromas,et al.  Evolution of the Cutaneous Immune Response to Experimental Haemophilus ducreyi Infection and Its Relevance to HIV-1 Acquisition1 2 , 2002, The Journal of Immunology.

[46]  K. Mills,et al.  Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. , 2002, Trends in immunology.

[47]  M. E. Bauer,et al.  Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control. , 2002, Microbes and infection.

[48]  Ying K. Tam,et al.  Cytokines in the generation and maturation of dendritic cells: recent advances. , 2002, European cytokine network.

[49]  R. Munson,et al.  Immunopathogenesis of Haemophilus ducreyi Infection (Chancroid) , 2002, Infection and Immunity.

[50]  D. Kasper,et al.  Role of T cells in abscess formation. , 2002, Current opinion in microbiology.

[51]  Ash A. Alizadeh,et al.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Joshua M. Korn,et al.  The plasticity of dendritic cell responses to pathogens and their components. , 2001, Science.

[53]  Y. Liu,et al.  Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity , 2001, Cell.

[54]  S. Dutro,et al.  Haemophilus ducreyi Inhibits Phagocytosis by U-937 Cells, a Human Macrophage-Like Cell Line , 2001, Infection and Immunity.

[55]  J. Banchereau,et al.  Sensing Pathogens and Tuning Immune Responses , 2001, Science.

[56]  S. Spinola,et al.  Characterization of Haemophilus ducreyi-Specific T-Cell Lines from Lesions of Experimentally Infected Human Subjects , 2001, Infection and Immunity.

[57]  W. Timens,et al.  Keratinocyte‐derived growth factors play a role in the formation of hypertrophic scars , 2001, The Journal of pathology.

[58]  M. E. Bauer,et al.  Haemophilus ducreyi Associates with Phagocytes, Collagen, and Fibrin and Remains Extracellular throughout Infection of Human Volunteers , 2001, Infection and Immunity.

[59]  C. Elkins,et al.  DsrA-Deficient Mutant of Haemophilus ducreyi Is Impaired in Its Ability To Infect Human Volunteers , 2001, Infection and Immunity.

[60]  R. Throm,et al.  Transcription of Candidate Virulence Genes ofHaemophilus ducreyi during Infection of Human Volunteers , 2001, Infection and Immunity.

[61]  S. Dower,et al.  Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells1 , 2001, The Journal of Immunology.

[62]  R. Peach,et al.  Bacterial Pathogens Induce Abscess Formation by CD4+ T-Cell Activation via the CD28–B7-2 Costimulatory Pathway , 2000, Infection and Immunity.

[63]  J. Mira,et al.  A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection , 2000, Infection and Immunity.

[64]  D. Botstein,et al.  Singular value decomposition for genome-wide expression data processing and modeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  K. Morrow,et al.  Serum Resistance in Haemophilus ducreyiRequires Outer Membrane Protein DsrA , 2000, Infection and Immunity.

[66]  D. Kasper,et al.  IL-2 mediates protection against abscess formation in an experimental model of sepsis. , 1999, Journal of immunology.

[67]  J. Al-Tawfiq,et al.  Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. , 1998, The Journal of infectious diseases.

[68]  S. Spinola,et al.  The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. , 1998, The Journal of infectious diseases.

[69]  H. Gudmundsdottir,et al.  Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. , 1997, The Journal of clinical investigation.

[70]  K. Fortney,et al.  Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. , 1996, The Journal of infectious diseases.

[71]  M. Apicella,et al.  Experimental human infection with Haemophilus ducreyi. , 1994, The Journal of infectious diseases.

[72]  S. Morse,et al.  Chancroid and Haemophilus ducreyi , 1989, Clinical Microbiology Reviews.

[73]  M. Apicella,et al.  Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae , 1986, Infection and immunity.

[74]  A. Ronald,et al.  Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. , 1980, Reviews of infectious diseases.

[75]  J. Wrana,et al.  Turning it up a Notch: cross-talk between TGF beta and Notch signaling. , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[76]  D. Clark Tolerance signaling molecules. , 2005, Chemical immunology and allergy.

[77]  H. Smits,et al.  Dendritic cell-mediated T cell polarization , 2004, Springer Seminars in Immunopathology.

[78]  E. Hansen,et al.  Haemophilus ducreyi Requires an Intact flp Gene Cluster for Virulence in Humans , 2003 .

[79]  B. Spellberg,et al.  Type 1/Type 2 immunity in infectious diseases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[80]  R. Steen,et al.  Eradicating chancroid. , 2001, Bulletin of the World Health Organization.

[81]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.